Dyslipidemia may be due to increased lipolysis from a highly inflammatory background, which would be aggravated in T2D where fatty tissues lose sensitivity to insulin’s anti-lipolytic effects. The gene discussed is INS; the disease is type 2 diabetes mellitus.